Chemicals · Founded 1983 · www.ghcl.co.in · BSE 500171 · NSE GHCL LTD · ISIN INE539A01019
No Notes Added Yet
Business
GHCL Ltd. is a leading Indian chemical company primarily engaged in the manufacture and sale of Soda Ash (Sodium Carbonate) and Sodium Bicarbonate (Baking Soda). It operates as one of the largest producers of Soda Ash in India. The company's core business model revolves around large-scale, integrated chemical manufacturing. It generates revenue by supplying these essential industrial chemicals to various end-user industries such as glass (flat glass, container glass), detergents, chemicals, paper, food, pharmaceuticals, and animal feed. Following the demerger of its Home Textiles business in FY23, GHCL is now a pure-play chemicals entity.
Revenue Mix
Post the demerger of its Home Textiles business into GHCL Textiles Ltd. (effective April 1, 2023), GHCL Ltd. operates primarily as a single segment, "Chemicals." Within this segment, the major products are:
Soda Ash (Sodium Carbonate): This is the flagship product, forming the bulk of its chemical revenue. It is produced in light and dense variants.
Sodium Bicarbonate (Baking Soda): This product caters to a wide range of applications, including food, pharmaceutical, animal feed, and industrial uses.
As GHCL is now a pure-play chemical company, revenue is almost entirely derived from the sale of these chemical products.
Industry
GHCL operates within the Indian chemicals industry, specifically in the commodity inorganic chemicals segment (Soda Ash, Sodium Bicarbonate). The Soda Ash industry globally is capital-intensive and characterized by a few large players due to economies of scale. In India, GHCL is one of the top producers, competing with other major domestic players like Tata Chemicals and Nirma. Its positioning is that of an established, integrated player with significant installed capacity, which provides a cost advantage. The industry is sensitive to global supply-demand dynamics and import competition, especially from countries with natural soda ash reserves or lower energy costs.
MOAT
GHCL's competitive advantages primarily stem from:
Scale and Cost Efficiency: As a large-scale manufacturer of Soda Ash, GHCL benefits from economies of scale, which are crucial in commodity chemical production. Its integrated manufacturing facilities contribute to cost competitiveness.
Backward Integration: The company has captive mining leases for key raw materials like limestone and salt, which helps in ensuring consistent supply and cost control.
Established Market Position: A long operational history and established relationships with a diverse customer base across various industries in India provide a degree of market stability.
Energy Efficiency Focus: Continuous investments in optimizing energy consumption and utilizing waste heat contribute to lowering production costs, a critical factor for energy-intensive chemicals.
Growth Drivers
Domestic Demand Growth: Continued growth in end-user industries such as glass (automotive, construction), detergents, and chemicals in India will drive demand for Soda Ash and Sodium Bicarbonate.
Capacity Expansion: Any ongoing or planned capacity expansions for Soda Ash and Sodium Bicarbonate will directly contribute to sales volume growth.
Product Diversification/Value Addition: Expanding into higher-margin derivatives of its core chemicals or developing new applications for Sodium Bicarbonate could enhance profitability.
Efficiency Improvements: Continued focus on process optimization, energy cost reduction, and sustainability initiatives can improve margins and competitiveness.
Reduced Import Dependency: Government initiatives or market conditions that favor domestic production over imports could benefit local manufacturers.
Risks
Commodity Price Volatility: Prices of Soda Ash and Sodium Bicarbonate are subject to global supply-demand dynamics, which can lead to significant price fluctuations impacting profitability.
Raw Material & Energy Price Fluctuations: Volatility in prices of key inputs like coal, lignite, salt, and limestone can directly affect production costs and margins.
Environmental Regulations: The chemical industry is subject to stringent environmental regulations. Compliance costs and potential operational restrictions due to new regulations pose a risk.
Import Competition: Cheaper imports, especially from countries with natural soda ash reserves, can exert pressure on domestic prices and market share.
Economic Slowdown: A slowdown in India's economy or the global economy can reduce demand from end-user industries, impacting sales volumes.
Foreign Exchange Fluctuations: As the company might import certain raw materials or export products, currency volatility can impact costs and revenues.
Management & Ownership
GHCL Ltd. is promoted by the Jaipuria family, with Mr. Sanjay Dalmia as the Chairman and Mr. R.S. Jalan as the Managing Director. The promoters hold a significant stake in the company, aligning their interests with those of other shareholders. The management team has extensive experience in the chemical industry, overseeing the company's growth and strategic initiatives, including the recent demerger. The ownership structure typically includes the promoter group, institutional investors (both domestic and foreign), and the public.
Outlook
GHCL's outlook is tied to the growth trajectory of its core chemical products, Soda Ash and Sodium Bicarbonate. The company benefits from its established position as a major domestic producer with integrated operations, which provides a degree of cost competitiveness. Domestic demand from key end-user sectors like glass and detergents is expected to remain robust, offering a stable demand base. However, as a commodity chemical producer, GHCL is susceptible to the cyclical nature of the industry, global price volatility, and potential import pressures. The ability to manage input costs, enhance operational efficiencies, and leverage any planned capacity expansions will be key to sustaining profitability and market share. The pure-play chemical focus post-demerger allows for clearer strategic alignment and capital allocation towards the chemical business.
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 798 | 823 | 830 | 793 | 779 | 781 | 796 | 721 | 757 | 791 |
| Other Income | 14 | 17 | 18 | 17 | 29 | 23 | 27 | 17 | 16 | 14 |
| Total Income | 813 | 840 | 849 | 810 | 807 | 805 | 823 | 738 | 773 | 804 |
| Total Expenditure | 648 | 639 | 614 | 582 | 549 | 563 | 599 | 564 | 598 | 615 |
| Operating Profit | 165 | 201 | 235 | 228 | 259 | 242 | 224 | 174 | 175 | 189 |
| Interest | 6 | 5 | 4 | 4 | 4 | 4 | 2 | 2 | 3 | 2 |
| Depreciation | 26 | 26 | 27 | 28 | 28 | 28 | 27 | 28 | 29 | 27 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 133 | 170 | 203 | 196 | 227 | 209 | 195 | 145 | 143 | 160 |
| Provision for Tax | 33 | 45 | 53 | 42 | 59 | 59 | 50 | 38 | 37 | 44 |
| Profit After Tax | 100 | 125 | 151 | 155 | 168 | 150 | 144 | 107 | 106 | 116 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 100 | 125 | 151 | 155 | 168 | 150 | 144 | 107 | 106 | 116 |
| Adjusted Earnings Per Share | 10.4 | 13 | 15.7 | 16.2 | 17.6 | 15.7 | 15 | 11.1 | 11.5 | 12.6 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2531 | 2784 | 2919 | 3341 | 3305 | 2491 | 3778 | 4551 | 3447 | 3183 | 3064 | 3065 |
| Other Income | 10 | 40 | 38 | 16 | 18 | 7 | 12 | 34 | 52 | 88 | 73 | 74 |
| Total Income | 2541 | 2824 | 2957 | 3357 | 3323 | 2499 | 3791 | 4585 | 3499 | 3271 | 3138 | 3138 |
| Total Expenditure | 1901 | 2103 | 2313 | 2582 | 2577 | 1895 | 2799 | 3064 | 2598 | 2306 | 2375 | 2376 |
| Operating Profit | 640 | 721 | 644 | 775 | 746 | 604 | 991 | 1520 | 901 | 965 | 763 | 762 |
| Interest | 165 | 137 | 127 | 127 | 120 | 74 | 64 | 39 | 27 | 17 | 10 | 9 |
| Depreciation | 82 | 86 | 110 | 117 | 131 | 111 | 117 | 94 | 102 | 112 | 111 | 111 |
| Exceptional Income / Expenses | -14 | -3 | 0 | 0 | 0 | 0 | 0 | 76 | 219 | 0 | 0 | 0 |
| Profit Before Tax | 380 | 495 | 407 | 531 | 495 | 418 | 811 | 1463 | 991 | 836 | 642 | 643 |
| Provision for Tax | 122 | 115 | 51 | 180 | 98 | 111 | 213 | 347 | 198 | 212 | 170 | 169 |
| Profit After Tax | 258 | 380 | 356 | 351 | 397 | 307 | 598 | 1116 | 794 | 624 | 472 | 473 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 19 | 48 | 26 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 258 | 380 | 356 | 351 | 397 | 326 | 647 | 1142 | 794 | 624 | 472 | 473 |
| Adjusted Earnings Per Share | 25.8 | 38.2 | 36.6 | 35.8 | 41.7 | 34.3 | 67.8 | 119.4 | 82.9 | 65.2 | 51.4 | 50.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | -12% | 4% | 2% |
| Operating Profit CAGR | -21% | -21% | 5% | 2% |
| PAT CAGR | -24% | -25% | 9% | 6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -40% | -14% | -3% | 3% |
| ROE Average | 13% | 19% | 22% | 22% |
| ROCE Average | 18% | 24% | 26% | 23% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1036 | 1347 | 1611 | 1926 | 2149 | 2484 | 3086 | 3956 | 2978 | 3489 | 3552 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 675 | 698 | 744 | 702 | 808 | 564 | 425 | 243 | 115 | 62 | 34 |
| Other Non-Current Liabilities | 198 | 242 | 201 | 259 | 274 | 277 | 295 | 262 | 262 | 267 | 275 |
| Total Current Liabilities | 1139 | 1331 | 1179 | 1108 | 1082 | 760 | 1334 | 415 | 414 | 368 | 438 |
| Total Liabilities | 3048 | 3617 | 3735 | 3995 | 4313 | 4085 | 5221 | 5133 | 3770 | 4185 | 4300 |
| Fixed Assets | 2049 | 2401 | 2493 | 2583 | 2664 | 2675 | 2474 | 1731 | 1842 | 1844 | 1821 |
| Other Non-Current Assets | 105 | 76 | 135 | 174 | 222 | 182 | 350 | 245 | 148 | 388 | 558 |
| Total Current Assets | 894 | 1141 | 1107 | 1200 | 1395 | 1217 | 1802 | 1539 | 1779 | 1954 | 1921 |
| Total Assets | 3048 | 3617 | 3735 | 3995 | 4313 | 4085 | 5221 | 5133 | 3770 | 4185 | 4300 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 31 | 39 | 9 | 12 | 12 | 92 | 35 | 244 | 123 | 49 | 99 |
| Cash Flow from Operating Activities | 509 | 458 | 590 | 530 | 624 | 621 | 643 | 856 | 797 | 638 | 687 |
| Cash Flow from Investing Activities | -249 | -375 | -279 | -271 | -206 | -109 | -337 | -409 | -534 | -358 | -291 |
| Cash Flow from Financing Activities | -252 | -113 | -308 | -258 | -339 | -569 | -98 | -530 | -338 | -230 | -451 |
| Net Cash Inflow / Outflow | 8 | -30 | 2 | 1 | 80 | -57 | 209 | -83 | -75 | 50 | -55 |
| Closing Cash & Cash Equivalent | 39 | 9 | 12 | 12 | 92 | 35 | 244 | 161 | 49 | 99 | 44 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 25.77 | 38.21 | 36.58 | 35.76 | 41.75 | 34.32 | 67.82 | 119.42 | 82.94 | 65.19 | 51.39 |
| CEPS(Rs) | 33.94 | 46.82 | 47.88 | 47.69 | 55.56 | 44.02 | 75 | 126.58 | 93.61 | 76.83 | 63.45 |
| DPS(Rs) | 3.5 | 5 | 5 | 5 | 3 | 5.5 | 15 | 17.5 | 12 | 12 | 12 |
| Book NAV/Share(Rs) | 103.57 | 135.37 | 165.35 | 194.38 | 225.14 | 260.27 | 323.03 | 412.31 | 309.81 | 363.08 | 385.73 |
| Core EBITDA Margin(%) | 23.25 | 22.9 | 20.41 | 22.73 | 22.03 | 22.43 | 24.89 | 31.69 | 22.81 | 24.79 | 20.02 |
| EBIT Margin(%) | 20.12 | 21.26 | 17.98 | 19.69 | 18.59 | 18.52 | 22.23 | 32.01 | 27.37 | 24.12 | 18.93 |
| Pre Tax Margin(%) | 14.02 | 16.66 | 13.72 | 15.88 | 14.96 | 15.73 | 20.61 | 31.18 | 26.65 | 23.62 | 18.65 |
| PAT Margin (%) | 9.52 | 12.79 | 12 | 10.49 | 12 | 11.54 | 15.21 | 23.78 | 21.34 | 17.64 | 13.72 |
| Cash Profit Margin (%) | 12.54 | 15.67 | 15.7 | 13.99 | 15.97 | 15.73 | 18.18 | 25.79 | 24.08 | 20.79 | 16.93 |
| ROA(%) | 8.74 | 11.4 | 9.69 | 9.07 | 9.55 | 7.31 | 12.86 | 21.55 | 17.83 | 15.69 | 11.14 |
| ROE(%) | 28.54 | 31.9 | 24.1 | 19.94 | 19.61 | 13.31 | 21.55 | 31.78 | 22.99 | 19.38 | 13.46 |
| ROCE(%) | 24.23 | 24.26 | 18.6 | 21.36 | 18.57 | 14.83 | 24.61 | 36.83 | 27.24 | 25.25 | 18.12 |
| Receivable days | 28.79 | 28.18 | 31.02 | 28.36 | 31.2 | 34.51 | 21.24 | 17.42 | 19.54 | 20.09 | 20.28 |
| Inventory Days | 66.78 | 66.78 | 75.03 | 76.75 | 86.09 | 106.68 | 79.23 | 66.78 | 69.82 | 65.84 | 64.77 |
| Payable days | 130.46 | 99.23 | 102.63 | 102.3 | 102.46 | 126.01 | 77.83 | 65.59 | 60.09 | 62.13 | 74.32 |
| PER(x) | 4.47 | 6.96 | 7.09 | 6.91 | 2.13 | 6.71 | 8.08 | 4.22 | 5.34 | 9.42 | 8.23 |
| Price/Book(x) | 1.11 | 1.96 | 1.57 | 1.27 | 0.39 | 0.88 | 1.7 | 1.22 | 1.43 | 1.69 | 1.1 |
| Dividend Yield(%) | 3.04 | 1.88 | 1.93 | 2.02 | 3.38 | 2.39 | 2.74 | 3.48 | 2.71 | 1.95 | 2.84 |
| EV/Net Sales(x) | 0.98 | 1.46 | 1.31 | 1.1 | 0.6 | 1.17 | 1.52 | 1.1 | 1.15 | 1.74 | 1.26 |
| EV/Core EBITDA(x) | 3.87 | 5.65 | 5.93 | 4.76 | 2.65 | 4.81 | 5.79 | 3.3 | 4.38 | 5.73 | 5.06 |
| Net Sales Growth(%) | 6.62 | 10 | 4.86 | 14.46 | -1.08 | -24.63 | 51.67 | 20.45 | -24.27 | -7.63 | -3.75 |
| EBIT Growth(%) | 27.2 | 16.06 | -15.52 | 23.22 | -6.62 | -19.84 | 77.54 | 71.74 | -32.2 | -16.16 | -23.6 |
| PAT Growth(%) | 41.7 | 47.45 | -6.24 | -1.62 | 13.13 | -22.64 | 94.99 | 86.5 | -28.85 | -21.38 | -24.3 |
| EPS Growth(%) | 41.7 | 48.26 | -4.26 | -2.23 | 16.73 | -17.78 | 97.59 | 76.08 | -30.55 | -21.41 | -21.16 |
| Debt/Equity(x) | 1.32 | 1.09 | 0.82 | 0.68 | 0.58 | 0.31 | 0.25 | 0.09 | 0.07 | 0.03 | 0.02 |
| Current Ratio(x) | 0.79 | 0.86 | 0.94 | 1.08 | 1.29 | 1.6 | 1.35 | 3.71 | 4.3 | 5.31 | 4.38 |
| Quick Ratio(x) | 0.34 | 0.42 | 0.4 | 0.39 | 0.56 | 0.6 | 0.64 | 1.85 | 2.73 | 3.61 | 3.02 |
| Interest Cover(x) | 3.3 | 4.62 | 4.22 | 5.17 | 5.13 | 6.63 | 13.75 | 38.83 | 38.23 | 48.83 | 66.68 |
| Total Debt/Mcap(x) | 1.19 | 0.55 | 0.52 | 0.54 | 1.47 | 0.35 | 0.15 | 0.07 | 0.05 | 0.02 | 0.02 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 19.04 | 19.04 | 19.04 | 19.04 | 18.97 | 18.97 | 19.83 | 19.87 | 19.83 | 19.83 |
| FII | 24.76 | 25.7 | 25.42 | 26.07 | 26.41 | 25.67 | 25.22 | 24.66 | 22.43 | 21.99 |
| DII | 9.3 | 9.81 | 10.37 | 10.11 | 10.29 | 10.53 | 9.5 | 10.57 | 11.21 | 11.52 |
| Public | 46.9 | 45.45 | 45.18 | 44.79 | 44.33 | 44.82 | 45.45 | 44.89 | 46.53 | 46.66 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.83 | 1.83 | 1.83 |
| FII | 2.37 | 2.46 | 2.43 | 2.5 | 2.54 | 2.47 | 2.32 | 2.27 | 2.07 | 2.03 |
| DII | 0.89 | 0.94 | 0.99 | 0.97 | 0.99 | 1.01 | 0.87 | 0.97 | 1.03 | 1.06 |
| Public | 4.49 | 4.35 | 4.33 | 4.29 | 4.26 | 4.31 | 4.18 | 4.13 | 4.29 | 4.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.58 | 9.58 | 9.58 | 9.58 | 9.61 | 9.61 | 9.19 | 9.19 | 9.21 | 9.21 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | -12% | +4% | +2% |
| Operating Profit CAGR | -21% | -21% | +5% | +2% |
| PAT CAGR | -24% | -25% | +9% | +6% |
| Share Price CAGR | -40% | -14% | -3% | +3% |
| ROE Average | +13% | +19% | +22% | +22% |
| ROCE Average | +18% | +24% | +26% | +23% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 19.04 | 19.04 | 19.04 | 19.04 | 18.97 | 18.97 | 19.83 | 19.87 | 19.83 | 19.83 |
| FII | 24.76 | 25.7 | 25.42 | 26.07 | 26.41 | 25.67 | 25.22 | 24.66 | 22.43 | 21.99 |
| DII | 9.3 | 9.81 | 10.37 | 10.11 | 10.29 | 10.53 | 9.5 | 10.57 | 11.21 | 11.52 |
| Public | 46.9 | 45.45 | 45.18 | 44.79 | 44.33 | 44.82 | 45.45 | 44.89 | 46.53 | 46.66 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.83 | 1.83 | 1.83 |
| FII | 2.37 | 2.46 | 2.43 | 2.5 | 2.54 | 2.47 | 2.32 | 2.27 | 2.07 | 2.03 |
| DII | 0.89 | 0.94 | 0.99 | 0.97 | 0.99 | 1.01 | 0.87 | 0.97 | 1.03 | 1.06 |
| Public | 4.49 | 4.35 | 4.33 | 4.29 | 4.26 | 4.31 | 4.18 | 4.13 | 4.29 | 4.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.58 | 9.58 | 9.58 | 9.58 | 9.61 | 9.61 | 9.19 | 9.19 | 9.21 | 9.21 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.